Is FRACTYL HEALTH, INC. (GUTS) Halal?

NASDAQ Healthcare United States $71M
✗ NOT HALAL
Confidence: 90/100
FRACTYL HEALTH, INC. (GUTS) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 84.9% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. FRACTYL HEALTH, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 84.9%
/ 30%
91.6%
/ 30%
0.0%
/ 30%
4458.06%
/ 5%
✗ NOT HALAL
DJIM 84.9%
/ 33%
91.6%
/ 33%
0.0%
/ 33%
4458.06%
/ 5%
✗ NOT HALAL
MSCI 57.8%
/ 33%
62.4%
/ 33%
0.0%
/ 33%
4458.06%
/ 5%
✗ NOT HALAL
S&P 84.9%
/ 33%
91.6%
/ 33%
0.0%
/ 33%
4458.06%
/ 5%
✗ NOT HALAL
FTSE 57.8%
/ 33%
62.4%
/ 33%
0.0%
/ 50%
4458.06%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1.86
P/B Ratio
7.2
EV/EBITDA
-0.5
EV: $51M
Revenue
$93,000
Beta
1.5
High volatility
Current Ratio
4.8

Profitability

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Return on Equity (ROE) -744.2%
Return on Assets (ROA) -52.7%

Cash Flow & Balance Sheet

Operating Cash Flow-$66M
Free Cash Flow-$67M
Total Debt$62M
Debt-to-Equity651.8
Current Ratio4.8
Total Assets$108M

Price & Trading

Last Close$0.47
50-Day MA$0.74
200-Day MA$1.33
Avg Volume5.5M
Beta1.5
52-Week Range
$0.38
$3.03

About FRACTYL HEALTH, INC. (GUTS)

CEO
Dr. Harith Rajagopalan M.D., Ph.D.
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$71M
Currency
USD

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is FRACTYL HEALTH, INC. (GUTS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), FRACTYL HEALTH, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is FRACTYL HEALTH, INC.'s debt ratio?

FRACTYL HEALTH, INC.'s debt ratio is 84.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 57.8%.

What are FRACTYL HEALTH, INC.'s key financial metrics?

FRACTYL HEALTH, INC. has a market capitalization of $71M, and revenue of $93,000. Return on equity stands at -744.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.